382 related articles for article (PubMed ID: 30069644)
1. Adoptive Cell Therapy in Treating Pediatric Solid Tumors.
Tesfaye M; Savoldo B
Curr Oncol Rep; 2018 Aug; 20(9):73. PubMed ID: 30069644
[TBL] [Abstract][Full Text] [Related]
2. CAR-T Therapies in Solid Tumors: Opportunities and Challenges.
Guzman G; Reed MR; Bielamowicz K; Koss B; Rodriguez A
Curr Oncol Rep; 2023 May; 25(5):479-489. PubMed ID: 36853475
[TBL] [Abstract][Full Text] [Related]
3. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.
Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557
[TBL] [Abstract][Full Text] [Related]
4. New developments in immunotherapy for pediatric solid tumors.
Schultz LM; Majzner R; Davis KL; Mackall C
Curr Opin Pediatr; 2018 Feb; 30(1):30-39. PubMed ID: 29189429
[TBL] [Abstract][Full Text] [Related]
5. Adoptive Cell Therapy in Pediatric and Young Adult Solid Tumors: Current Status and Future Directions.
Ligon JA; Wessel KM; Shah NN; Glod J
Front Immunol; 2022; 13():846346. PubMed ID: 35273619
[TBL] [Abstract][Full Text] [Related]
6. Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead.
Kirtane K; Elmariah H; Chung CH; Abate-Daga D
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34301811
[TBL] [Abstract][Full Text] [Related]
7. Challenges and prospects of chimeric antigen receptor T cell therapy in solid tumors.
Jindal V; Arora E; Gupta S
Med Oncol; 2018 May; 35(6):87. PubMed ID: 29730801
[TBL] [Abstract][Full Text] [Related]
8. Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward.
Li J; Li W; Huang K; Zhang Y; Kupfer G; Zhao Q
J Hematol Oncol; 2018 Feb; 11(1):22. PubMed ID: 29433552
[TBL] [Abstract][Full Text] [Related]
9. Adoptive T-Cell Therapy for Solid Malignancies.
Jafferji MS; Yang JC
Surg Oncol Clin N Am; 2019 Jul; 28(3):465-479. PubMed ID: 31079800
[TBL] [Abstract][Full Text] [Related]
10. Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors.
Zhang BL; Qin DY; Mo ZM; Li Y; Wei W; Wang YS; Wang W; Wei YQ
Sci China Life Sci; 2016 Apr; 59(4):340-8. PubMed ID: 26965525
[TBL] [Abstract][Full Text] [Related]
11. Driving CARs on the Highway to Solid Cancer: Some Considerations on the Adoptive Therapy with CAR T Cells.
Abken H
Hum Gene Ther; 2017 Nov; 28(11):1047-1060. PubMed ID: 28810803
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies.
Casey DL; Cheung NV
Cancer Immunol Res; 2020 Feb; 8(2):161-166. PubMed ID: 32015013
[TBL] [Abstract][Full Text] [Related]
13. Redirecting T cells to treat solid pediatric cancers.
Rauwolf KK; Rossig C
Cancer Metastasis Rev; 2019 Dec; 38(4):611-624. PubMed ID: 31811551
[TBL] [Abstract][Full Text] [Related]
14. T-cell receptor and chimeric antigen receptor in solid cancers: current landscape, preclinical data and insight into future developments.
Azizi AA; Pillai M; Thistlethwaite FC
Curr Opin Oncol; 2019 Sep; 31(5):430-438. PubMed ID: 31335828
[TBL] [Abstract][Full Text] [Related]
15. Making CAR T Cells a Solid Option for Solid Tumors.
Schmidts A; Maus MV
Front Immunol; 2018; 9():2593. PubMed ID: 30467505
[TBL] [Abstract][Full Text] [Related]
16. Adoptive Cellular Therapy for Pediatric Solid Tumors: Beyond Chimeric Antigen Receptor-T Cell Therapy.
Hensel J; Metts J; Gupta A; Ladle BH; Pilon-Thomas S; Mullinax J
Cancer J; 2022 Jul-Aug 01; 28(4):322-327. PubMed ID: 35880942
[TBL] [Abstract][Full Text] [Related]
17. CAR T Cell Therapy for Solid Tumors.
Newick K; O'Brien S; Moon E; Albelda SM
Annu Rev Med; 2017 Jan; 68():139-152. PubMed ID: 27860544
[TBL] [Abstract][Full Text] [Related]
18. Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors.
Zhang E; Gu J; Xu H
Mol Cancer; 2018 Jan; 17(1):7. PubMed ID: 29329591
[TBL] [Abstract][Full Text] [Related]
19. Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research.
Wang Z; Cao YJ
Front Immunol; 2020; 11():176. PubMed ID: 32194541
[TBL] [Abstract][Full Text] [Related]
20. Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology.
Watanabe K; Kuramitsu S; Posey AD; June CH
Front Immunol; 2018; 9():2486. PubMed ID: 30416506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
